Levetiracetam Zentiva

Levetiracetam, the active ingredient in Levetiracetam Zentiva, is an antiepileptic presented as an oral tablet for oral use. It is employed as adjunctive therapy to control partial‑onset, generalized tonic‑clonic and myoclonic seizures in patients with epilepsy. The medication is approved in the European Union and is prescribed by neurologists as part of a comprehensive seizure management plan.

GNH USA supplies Levetiracetam Zentiva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. Our distribution network ensures reliable delivery and regulatory compliance across multiple regions.

Levetiracetam is an antiepileptic drug used to manage seizure disorders by modulating neuronal excitability.

Partial‑onset seizures: Reduces frequency of focal seizures when added to existing therapy. Generalized tonic‑clonic seizures: Provides adjunctive control of bilateral convulsive seizures. Myoclonic seizures: Helps decrease rapid, brief muscle jerks as part of combination treatment.

Levetiracetam may be associated with a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Drowsiness: Feeling unusually sleepy or fatigued. - Dizziness: Light‑headed sensation, especially when standing quickly. - Headache: Mild to moderate cranial pain. - Irritability: Mood changes including agitation or aggression.

Serious or Rare Side Effects: - Severe allergic reaction: Rash, swelling, or difficulty breathing requiring immediate medical attention. - Psychiatric disturbances: New or worsening depression, suicidal thoughts, or psychosis. - Blood disorders: Unexplained bruising, bleeding, or low blood cell counts.

When prescribing Levetiracetam, clinicians should consider several safety precautions to optimize patient outcomes.

Renal impairment: Adjust dose in patients with reduced kidney function. History of psychiatric illness: Monitor for mood changes or suicidal ideation. Concomitant CNS depressants: Use caution as combined sedation may increase. Pregnancy and lactation: Evaluate risk‑benefit ratio before use. Store at ambient temperature: Keep below 25 °C in the original container, protected from moisture.

Levetiracetam can interact with other medicines, influencing its efficacy or safety profile.

Major Interactions (Avoid): - Carbamazepine: May reduce levetiracetam plasma levels, decreasing effectiveness. - Phenobarbital: Can lower levetiracetam concentrations, requiring close monitoring.

Moderate Interactions (Monitor Closely): - Alcohol: Combined use may enhance central nervous system depression. - Other antiepileptics (e.g., valproate): May require dose adjustments based on clinical response. - Oral contraceptives: Levetiracetam may slightly reduce hormonal contraceptive efficacy; consider additional contraceptive methods.